{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:00:43Z","timestamp":1790992843941,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["BFU2012-37907"],"award-info":[{"award-number":["BFU2012-37907"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["BFU2012-37087"],"award-info":[{"award-number":["BFU2012-37087"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["SAF2008-03118-E"],"award-info":[{"award-number":["SAF2008-03118-E"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["SAF39875-C02-01"],"award-info":[{"award-number":["SAF39875-C02-01"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"FEDER","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.bcp.2015.05.006","type":"journal-article","created":{"date-parts":[[2015,5,16]],"date-time":"2015-05-16T05:27:26Z","timestamp":1431754046000},"page":"131-142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"title":["Dopamine D2 and angiotensin II type 1 receptors form functional heteromers in rat striatum"],"prefix":"10.1016","volume":"96","author":[{"given":"E.","family":"Mart\u00ednez-Pinilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.I.","family":"Rodr\u00edguez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Aguinaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.L.","family":"Lanciego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.L.","family":"Labandeira-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2015.05.006_bib0320","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/0166-2236(89)90074-X","article-title":"The functional anatomy of basal ganglia disorders","volume":"12","author":"Albin","year":"1989","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bcp.2015.05.006_bib0325","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0166-2236(90)90110-V","article-title":"Primate models of movement disorders of basal ganglia origin","volume":"13","author":"DeLong","year":"1990","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bcp.2015.05.006_bib0330","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1748-1716.1987.tb08080.x","article-title":"The dopamine-gamma aminobutyric acid interaction in the striatum of the rat is differently regulated by dopamine D-1 and D-2 types of receptor: evidence obtained with rotational behavioural experiments","volume":"129","author":"Herrera-Marschitz","year":"1987","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.bcp.2015.05.006_bib0335","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1172\/JCI106797","article-title":"Angiotensin II vascular receptors: their avidity in relationship to sodium balance, the autonomic nervous system, and hypertension","volume":"51","author":"Brunner","year":"1972","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2015.05.006_bib0340","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0006-8993(81)90019-6","article-title":"Localization of immunoreactive angiotensin II in the hippocampus and striatum of rat brain","volume":"217","author":"Sirett","year":"1981","journal-title":"Brain Res."},{"key":"10.1016\/j.bcp.2015.05.006_bib0345","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s10571-005-4011-5","article-title":"Brain angiotensin II: new developments, unanswered questions and therapeutic opportunities","volume":"25","author":"Saavedra","year":"2005","journal-title":"Cell Mol. Neurobiol."},{"key":"10.1016\/j.bcp.2015.05.006_bib0350","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00109-008-0331-5","article-title":"Brain renin angiotensin in disease","volume":"86","author":"Phillips","year":"2008","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.bcp.2015.05.006_bib0355","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.3201232","article-title":"Astrocytes synthesize angiotensinogen in brain","volume":"242","author":"Stornetta","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.bcp.2015.05.006_bib0360","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1073\/pnas.87.15.5720","article-title":"Astrocyte cultures derived from human brain tissue express angiotensinogen mRNA","volume":"87","author":"Milsted","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2015.05.006_bib0365","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/jnr.490190302","article-title":"Angiotensinogen gene expression in neuronal and glial cells in primary cultures of rat brain","volume":"19","author":"Kumar","year":"1988","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bcp.2015.05.006_bib0370","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0006-8993(92)91575-Y","article-title":"Angiotensinogen is secreted by pure rat neuronal cell cultures","volume":"588","author":"Thomas","year":"1992","journal-title":"Brain Res."},{"key":"10.1016\/j.bcp.2015.05.006_bib0375","first-page":"471","article-title":"Angiotensin biosynthesis and concentrations in brain of normotensive and hypertensive rats","volume":"79","author":"Hermann","year":"1984","journal-title":"J. Physiol."},{"key":"10.1016\/j.bcp.2015.05.006_bib0380","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/NEN.0b013e3181fa0308","article-title":"Location of prorenin receptors in primate substantia nigra: effects on dopaminergic cell death","volume":"69","author":"Valenzuela","year":"2010","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bcp.2015.05.006_bib0385","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJM198505303122202","article-title":"Increased plasma inactive renin in diabetes mellitus. A marker of microvascular complications","volume":"312","author":"Luetscher","year":"1985","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2015.05.006_bib0390","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.nbd.2008.03.003","article-title":"Brain angiotensin enhances dopaminergic cell death via microglial activation and NADPH-derived ROS","volume":"31","author":"Rodriguez-Pallares","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bcp.2015.05.006_bib0395","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00429-012-0402-9","article-title":"Expression of angiotensinogen and receptors for angiotensin and prorenin in the monkey and human substantia nigra: an intracellular renin-angiotensin system in the nigra","volume":"218","author":"Garrido-Gil","year":"2013","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.bcp.2015.05.006_bib0400","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0031-6997(25)00446-6","article-title":"Angiotensin II receptors and angiotensin II receptor antagonists","volume":"45","author":"Timmermans","year":"1993","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bcp.2015.05.006_bib0405","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0361-9230(90)90226-P","article-title":"Evidence for the presence of angiotensin II-type 1 receptors in brain","volume":"25","author":"Wamsley","year":"1990","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.bcp.2015.05.006_bib0410","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/351233a0","article-title":"Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor","volume":"351","author":"Murphy","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2015.05.006_bib0415","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/351230a0","article-title":"Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor","volume":"351","author":"Sasaki","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2015.05.006_bib0420","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1159\/000126177","article-title":"Analysis of angiotensin II receptor subtypes in individual rat brain nuclei","volume":"55","author":"Rowe","year":"1992","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.bcp.2015.05.006_bib0425","doi-asserted-by":"crossref","first-page":"9455","DOI":"10.1016\/S0021-9258(19)50109-0","article-title":"Cloning and expression of a novel angiotensin II receptor subtype","volume":"267","author":"Sandberg","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2015.05.006_bib0430","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-1-4899-1376-0_10","article-title":"Interactions of angiotensin II with central dopamine","volume":"396","author":"Jenkins","year":"1996","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bcp.2015.05.006_bib0435","first-page":"67","article-title":"Brain renin-angiotensin system and dopaminergic cell vulnerability","volume":"8","author":"Labandeira-Garcia","year":"2014","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.bcp.2015.05.006_bib0440","first-page":"860923","article-title":"Importance of the brain Angiotensin system in Parkinson's disease","author":"Wright","year":"2012","journal-title":"Parkinsons Dis."},{"key":"10.1016\/j.bcp.2015.05.006_bib0445","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.expneurol.2013.10.014","article-title":"The angiotensin converting enzyme inhibitor captopril protects nigrostriatal dopamine neurons in animal models of parkinsonism","volume":"250","author":"Sonsalla","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bcp.2015.05.006_bib0450","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.neuropharm.2013.05.025","article-title":"Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of \u03b1-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL\/6J mice","volume":"73","author":"Sathiya","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2015.05.006_bib0455","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.expneurol.2014.08.019","article-title":"Angiotensin type 1 receptor blockage reduces l-dopa-induced dyskinesia in the 6-OHDA model of Parkinson's disease. Involvement of vascular endothelial growth factor and interleukin-1\u03b2","volume":"261","author":"Mu\u00f1oz","year":"2014","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bcp.2015.05.006_bib0460","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/HYPERTENSIONAHA.111.184788","article-title":"Mechanisms of dopamine D(1) and angiotensin type 2 receptor interaction in natriuresis","volume":"59","author":"Padia","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.bcp.2015.05.006_bib0465","first-page":"226","article-title":"Brain angiotensin and dopaminergic degeneration: relevance to Parkinson's disease","volume":"1","author":"Labandeira-Garcia","year":"2012","journal-title":"Am. J. Neurodegener. Dis."},{"key":"10.1016\/j.bcp.2015.05.006_bib0470","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/mds.25614","article-title":"Dopamine-angiotensin interactions in the basal ganglia and their relevance for Parkinson's disease","volume":"28","author":"Labandeira-Garcia","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bcp.2015.05.006_bib0475","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1681\/ASN.2011040344","article-title":"Binding of losartan to angiotensin AT1 receptors increases dopamine D1 receptor activation","volume":"23","author":"Li","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bcp.2015.05.006_bib0480","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/01.HYP.0000047880.78462.0E","article-title":"Angiotensin II regulation of AT1 and D3 dopamine receptors in renal proximal tubule cells of SHR","volume":"41","author":"Zeng","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.bcp.2015.05.006_bib0485","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1161\/01.HYP.0000085334.34963.4E","article-title":"Perturbation of D1 dopamine and AT1 receptor interaction in spontaneously hypertensive rats","volume":"42","author":"Zeng","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.bcp.2015.05.006_bib0490","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1161\/01.HYP.0000155212.33212.99","article-title":"Interaction of angiotensin II type 1 and D5 dopamine receptors in renal proximal tubule cells","volume":"45","author":"Zeng","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.bcp.2015.05.006_bib0495","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/978-1-62703-230-8_10","article-title":"Super-resolution microscopy of the neuronal calcium-binding proteins Calneuron-1 and Caldendrin. Calneuron-1 and Caldendrin","volume":"963","author":"Hradsky","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bcp.2015.05.006_bib0500","doi-asserted-by":"crossref","first-page":"28058","DOI":"10.1074\/jbc.M109.034231","article-title":"Interactions between calmodulin, adenosine A2A, and dopamine D2 receptors","volume":"284","author":"Navarro","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2015.05.006_bib0505","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nature12354","article-title":"Ultra-sensitive fluorescent proteins for imaging neuronal activity","volume":"499","author":"Chen","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2015.05.006_bib0510","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1161\/01.RES.0000012460.85923.F0","article-title":"Brain-selective overexpression of angiotensin (AT1) receptors causes enhanced cardiovascular sensitivity in transgenic mice","volume":"90","author":"Lazartigues","year":"2002","journal-title":"Circul. Res."},{"key":"10.1016\/j.bcp.2015.05.006_bib0515","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.expneurol.2010.05.015","article-title":"Estrogen and angiotensin interaction in the substantia nigra. Relevance to postmenopausal Parkinson's disease","volume":"224","author":"Rodriguez-Perez","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bcp.2015.05.006_bib0520","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1210\/endo.138.1.4879","article-title":"Pregnancy induces an increase in angiotensin II type-1 receptor expression in uterine but not systemic artery endothelium","volume":"138","author":"Bird","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2015.05.006_bib0525","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2144\/000113719","article-title":"Detection of antigen interactions ex vivo by proximity ligation assay: endogenous dopamine D2-adenosine A2A receptor complexes in the striatum","volume":"51","author":"Trifilieff","year":"2011","journal-title":"Biotechniques"},{"key":"10.1016\/j.bcp.2015.05.006_bib0530","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S0026-895X(25)13640-7","article-title":"Development of polyclonal anti-D2 dopamine receptor antibodies using sequence-specific peptides","volume":"43","author":"Boundy","year":"1993","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2015.05.006_bib0535","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/cne.10086","article-title":"Dopamine D2 receptors are present in prefrontalcortical afferents and their targets in patches of the rat caudate-putamen nucleus","volume":"442","author":"Wang","year":"2002","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.bcp.2015.05.006_bib0540","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nchembio0309-131","article-title":"Building a new conceptual framework for receptor heteromers","volume":"5","author":"Ferre","year":"2009","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bcp.2015.05.006_bib0545","doi-asserted-by":"crossref","first-page":"e1001347","DOI":"10.1371\/journal.pbio.1001347","article-title":"Circadian-related heteromerization of adrenergic and dopamine D(4) receptors modulates melatonin synthesis and release in the pineal gland","volume":"10","author":"Gonzalez","year":"2012","journal-title":"PLoS Biol."},{"key":"10.1016\/j.bcp.2015.05.006_bib0550","doi-asserted-by":"crossref","first-page":"5387","DOI":"10.1111\/bph.12850","article-title":"Heteromerization of GPR55 and cannabinoid CB receptors modulates signaling","volume":"171","author":"Balenga","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2015.05.006_bib0555","doi-asserted-by":"crossref","first-page":"20851","DOI":"10.1074\/jbc.M111.335273","article-title":"Cannabinoid receptors CB1 and CB2 form functional heteromers in brain","volume":"287","author":"Callen","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2015.05.006_bib0560","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.expneurol.2014.06.017","article-title":"CB and GPR55 receptors are co-expressed and form heteromers in rat and monkey striatum","volume":"261","author":"Martinez-Pinilla","year":"2014","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bcp.2015.05.006_bib0565","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.neuropharm.2013.10.036","article-title":"Franco R. l-DOPA-treatment in primates disrupts the expression of A2A adenosine-CB1 cannabinoid-D2 dopamine receptor heteromers in the caudate nucleus","volume":"79","author":"Bonaventura","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2015.05.006_bib0570","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ymeth.2008.06.014","article-title":"Characterizing proteins and their interactions in cells and tissues using the in situ proximity ligation assay","volume":"45","author":"Soderberg","year":"2008","journal-title":"Methods"},{"key":"10.1016\/j.bcp.2015.05.006_bib0575","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0361-9230(98)00039-2","article-title":"Angiotensin receptors in the nervous system","volume":"47","author":"Allen","year":"1998","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.bcp.2015.05.006_bib0580","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/ana.410320306","article-title":"Angiotensin II receptor binding associated with nigrostriatal dopaminergic neurons in human basal ganglia","volume":"32","author":"Allen","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bcp.2015.05.006_bib0585","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.1471-4159.2009.05999.x","article-title":"The inflammatory response in the MPTP model of Parkinson's disease is mediated by brain angiotensin: relevance to progression of the disease","volume":"109","author":"Joglar","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bcp.2015.05.006_bib0590","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0006-8993(93)90902-Y","article-title":"Effects of angiotensin II on dopamine and serotonin turnover in the striatum of conscious rat","volume":"613","author":"Mendelsohn","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.bcp.2015.05.006_bib0595","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1476-5381.1996.tb15418.x","article-title":"Ability of angiotensin II to modulate striatal dopamine release via AT1 receptor in vitro and in vivo","volume":"18","author":"Brown","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2015.05.006_bib0600","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1111\/j.1460-9568.2010.07448.x","article-title":"Nigral and striatal regulation of angiotensin receptor expression by dopamine and angiotensin in rodents: implications for progression of Parkinson's disease","volume":"32","author":"Villar-Cheda","year":"2010","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bcp.2015.05.006_bib0605","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1016\/j.neurobiolaging.2014.01.017","article-title":"Aging-related dysregulation of dopamine and angiotensin receptor interaction","volume":"35","author":"Villar-Cheda","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bcp.2015.05.006_bib0610","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1073\/pnas.0604049104","article-title":"D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq\/11 in the striatum","volume":"104","author":"Rashid","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2015.05.006_bib0615","doi-asserted-by":"crossref","first-page":"e16088","DOI":"10.1371\/journal.pone.0016088","article-title":"Striatal pre- and postsynaptic profile of adenosine A(2A) receptor antagonists","volume":"6","author":"Orru","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2015.05.006_bib0620","article-title":"Beneficial effect of candesartan and lisinopril against haloperidol-induced tardive dyskinesia in rat","author":"Thakur","year":"2014","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"key":"10.1016\/j.bcp.2015.05.006_bib0625","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-94-011-8123-5_4","article-title":"Drug-induced tardive dyskinesia","volume":"6","author":"Itoh","year":"1981","journal-title":"Curr. Dev. Psychopharmacol."},{"key":"10.1016\/j.bcp.2015.05.006_bib0630","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12888-014-0280-1","article-title":"Movement disorders in neuroleptic-na\u00efve patients with schizophrenia spectrum disorders","volume":"4","author":"Ayehu","year":"2014","journal-title":"BMC Psychiatry"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629521500252X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629521500252X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:38:57Z","timestamp":1748392737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000629521500252X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S000629521500252X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2015.05.006","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dopamine D2 and angiotensin II type 1 receptors form functional heteromers in rat striatum","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2015.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}